Tripmiddelen: cannabis

  • Hylke Vervaeke

De Cannabis sativa , Nederlandse naam ‘hennep’, is een plant die in grote delen van de wereld in de vrije natuur voorkomt. Zowel in de tropen en subtropen als in de gematigde klimaatzones gedijt hij uitstekend. Sinds mensenheugenis wordt de plant voor verschillende doeleinden gekweekt: als grondstof voor textiel, als medicijn en natuurlijk wegens de psychoactieve eigenschappen, al dan niet toegepast in religieuze ceremonies. Het is één van de oudste cultuurplanten.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barbers RG. et al. Differential examination of bronchoalveolar lavage cells in tobacco cigarette and marijuana smokers. Am Rev Respir Dis 1987; 135(6): 1271–1275.PubMedGoogle Scholar
  2. Bloom JW. et al. Respiratory effects of non-tobacco cigarettes. Br Med J (Clin Res Ed) 1987; 295(6612): 1516–1518.CrossRefGoogle Scholar
  3. Brink W van den. Hoe schadelijk zijn softdrugs? Justitie verken 2006; 32: 72–88.Google Scholar
  4. Brink W van den. Verslaving: een chronisch recidiverende hersenziekte. Justitie verken 2006; 32: 59–75.Google Scholar
  5. Carai MA, Colombo G, Gessa GL. Rimonabant: the first therapeutically relevant cannabinoid antagonist. Life Sci 2005; 77(19): 2339–2350.PubMedCrossRefGoogle Scholar
  6. Christensen R. et al. Efficacy and safety of the weight-loss drug rimonabant: a metaanalysis of randomised trials. Lancet 2007; 370(9600): 1706–1713.PubMedCrossRefGoogle Scholar
  7. Coates RA. et al. Cofactors of progression to acquired immunodeficiency syndrome in a cohort of male sexual contacts of men with human immunodeficiency virus disease. Am J Epidemiol 1990; 132(4): 717–722.PubMedGoogle Scholar
  8. Decorte T, Muys M, Slock S. Cannabis in Vlaanderen. Patronen van cannabisgebruik bij ervaren gebruikers. Leuven/Leusden: Acco; 2003.Google Scholar
  9. Devane WA. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258(5090): 1946–1949.PubMedCrossRefGoogle Scholar
  10. Di Marzo V, Petrocellis LD. Plant, synthetic, and endogenous cannabinoids in medicine. Annu Rev Med 2006; 57: 553–574.PubMedCrossRefGoogle Scholar
  11. El-Gohary M, Eid MA. Effect of cannabinoid ingestion (in the form of bhang) on the immune system of high school and university students. Hum Exp Toxicol 2004; 23(3): 149–156.PubMedCrossRefGoogle Scholar
  12. Fergusson DM. et al. Cannabis and psychosis. Bmj 2006; 332(7534): 172–175.PubMedCrossRefGoogle Scholar
  13. Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 2006; 101(4): 556–569.PubMedCrossRefGoogle Scholar
  14. Fergusson DM, Horwood LJ, Beautrais AL. Cannabis and educational achievement. Addiction 2003; 98(12): 1681–1692.PubMedCrossRefGoogle Scholar
  15. Fried PA. Prenatal exposure to tobacco and marijuana: effects during pregnancy, infancy, and early childhood. Clin Obstet Gynecol 1993; 36(2): 319–317.PubMedCrossRefGoogle Scholar
  16. Gieringer D. Marijuana research: Waterpipe study. MAPS (Multidisciplinary Association for Psychedelic Studies) Bulletin 1996; 6: 59–66.Google Scholar
  17. Gong H. et al. Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco. Am Rev Respir Dis 1987; 136(1): 142–149.PubMedGoogle Scholar
  18. Hall W, Christie M, Currow D. Cannabinoids and cancer: causation, remediation, and palliation. Lancet Oncol 2005; 6(1): 35–42.PubMedGoogle Scholar
  19. Harrison GP. et al. Cognitive measures in long-term cannabis users. J Clin Pharmacol 2002; 42(11 Suppl): 41S–47S.PubMedGoogle Scholar
  20. Hashibe M. et al. Epidemiologic review of marijuana use and cancer risk. Alcohol 2005; 35(3): 265–265.PubMedCrossRefGoogle Scholar
  21. Hashibe M. et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2006; 15(10): 1829–1824.PubMedCrossRefGoogle Scholar
  22. Hazekamp A. et al. Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. J Pharm Sci 2006; 95(6): 1308–1317.PubMedCrossRefGoogle Scholar
  23. Heishman SJ, Stitzer ML, Yingling JE. Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance. Pharmacol Biochem Behav 1989; 34(1): 173–179.PubMedCrossRefGoogle Scholar
  24. Hollister L. Marijuana and immunity. J Psychoactive Drugs 1992; 24: 159–164.PubMedGoogle Scholar
  25. Iversen L. The science of marijuana. Oxford: University Press; 2000.Google Scholar
  26. Kaslow R. et al. No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals: a report from the Multicentre AIDS Cohort Study, JAMA 1989; 261: 3424–3429.PubMedCrossRefGoogle Scholar
  27. Korf D. De normalisering van cannabisgebruik. Justitie verken 2006; 32: 61–71.Google Scholar
  28. Korf DJ. Dutch coffee shops and trends in cannabis use. Addict Behav 2002; 27(6): 851–866.PubMedCrossRefGoogle Scholar
  29. Korf DJ. et al. Sterke wiet. Een onderzoek naar blowgedrag, schadelijkheid en afhankelijkheid van cannabis. Amsterdam: Rozenberg Publishers; 2004.Google Scholar
  30. Kraft U. Natural High. Scien Am Mind 2006; 17: 61–65.Google Scholar
  31. Laar M van. et al. Nationale Drug Monitor. Jaarbericht 2006. Utrecht: Trimbos Instituut; 2007.Google Scholar
  32. Lyketsos CG. et al. Cannabis use and cognitive decline in persons under 65 years of age. Am J Epidemiol 1999; 149(9): 794–800.PubMedGoogle Scholar
  33. Lynskey MT. et al. Stimulant use and symptoms of abuse/dependence: epidemiology and associations with cannabis use - a twin study. Drug Alcohol Depend 2007; 86(2-3): 147–153.PubMedCrossRefGoogle Scholar
  34. Moore TH. et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370(9584): 319–328.PubMedCrossRefGoogle Scholar
  35. Morral AR, McCaffrey DF, Paddock SM. Reassessing the marijuana gateway effect. Addiction 2002; 97(12): 1493–1504.PubMedCrossRefGoogle Scholar
  36. Niesink R. et al. THC-concentraties in wiet, nederwiet en hasj in Nederlandse coffeeshops (2005–2006). Utrecht: Trimbos Instituut, DIMS; 2006.Google Scholar
  37. Pacifici R. et al. Modulation of the immune system in cannabis users. Jama 2003; 289(15): 1929–1931.PubMedCrossRefGoogle Scholar
  38. Pope HG. et al. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend 2003; 69(3): 303–310.PubMedCrossRefGoogle Scholar
  39. Russo E, Guy GW. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses 2006; 66(2): 234–246.PubMedCrossRefGoogle Scholar
  40. Scharen H van. De Cannabis connectie. Antwerpen: Uitgeverij Hadewijch; 1997.Google Scholar
  41. Segev L, Paz A, Potasman I. Drug abuse in travelers to southeast Asia: an on-site study. J Travel Med 2005; 12(4): 205–209.PubMedGoogle Scholar
  42. Solowij N. et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. Jama 2002; 287(9): 1123–1131.PubMedCrossRefGoogle Scholar
  43. Stella N. Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997; 388(6644): 773–778.PubMedCrossRefGoogle Scholar
  44. Sydow K von. et al. What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults. Drug Alcohol Depend 2002; 68(1): 49–64.CrossRefGoogle Scholar
  45. Tashkin D. et al. Effects of habitual use of marijuana and/or cocaine on the lung. In: Research findings on smoking of abused substances. NIDA Research Monograph 1997; 99: 63–87.Google Scholar
  46. Tashkin, DP. et al. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis 1987; 135(1): 209–216.PubMedGoogle Scholar
  47. Tashkin DP. et al. Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol 2002; 42(11 Suppl): 718–781.Google Scholar
  48. Taylor D. et al. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 2002; 97: 1055–1061.PubMedCrossRefGoogle Scholar
  49. Zuckerman B. et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989; 320(12): 762–768.PubMedGoogle Scholar


  1. Evidence-based Electronic Library for Drugs and Addiction.

Copyright information

© Bohn Stafleu van Loghum 2008

Authors and Affiliations

  • Hylke Vervaeke

There are no affiliations available

Personalised recommendations